Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
A NEW Member Benefit for 2021
Welcome to the December issue of RF Quarterly which focuses on key takeaways from the RAPS Convergence 2021, including patient-focused approaches in regulatory decision making and drug development, the transition from convergence to harmonization for global pharmaceutical regulatory requirements, pediatric drug development, and regulatory and clinical strategies.
Login now to view RF Quarterly
4 Patient-reported outcomes and patient preference information in
regulatory decision making
Richard Jahn, JD, MS; Bert Regeer, MD; Brett Hauber, PhD;
Nathalie Bere, MPH; and Theresa Mullin, PhD
15 ICH implementation: The transition from convergence to harmonization
Jerry Stewart, JD, MS, RPh; Theresa Mullin, PhD; and Petra Doerr, PhD
23 Pediatric drug development: Increasing success and overcoming obstacles
Linda McBride, RPh, RAC; Karl-Heinz Huemer, MD, PhD; and
Kimberly Belsky, MS
30 Regulatory strategy and clinical strategy: Where do they converge and diverge?
Angela Mallery, EdD; and
Pamela Wolfe, MBA, MS, CCRP, ACRP-CP, ACRP-MDP, FACRP
Not a RAPS Member? RAPS Membership gives you access to countless resources and a vast network of professional all dedicated to regulatory.
Learn more about RAPS Membership and Benefits.